Ceva Develops Vectormune HVT AIV vaccine

UK - Ceva announced the successful development and subsequent USDA approval of Vectormune HVT AIV, a recombinant vaccine against Avian Influenza (AI), at the 8th International Symposium on AI.
calendar icon 11 April 2012
clock icon 2 minute read
© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.